Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_provenance.
- NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_provenance.
- NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_assertion evidence source_evidence_literature NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_provenance.
- NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_assertion SIO_000772 23806066 NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_provenance.
- NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_assertion wasDerivedFrom befree-2016 NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_provenance.
- NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_assertion wasGeneratedBy ECO_0000203 NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_provenance.
- befree-2016 importedOn "2016-02-19" NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_provenance.